Mackay Shields LLC’s Arrowhead Research ARWR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-32,600
Closed -$2.16M 755
2021
Q1
$2.16M Sell
32,600
-20,426
-39% -$1.58M 0.02% 736
2020
Q4
$4.07M Sell
53,026
-7,000
-12% -$448K 0.03% 548
2020
Q3
$2.58M Sell
60,026
-4,400
-7% -$190K 0.02% 681
2020
Q2
$2.78M Buy
64,426
+9,000
+16% +$318K 0.02% 617
2020
Q1
$1.59M Sell
55,426
-1,900
-3% -$76.6K 0.01% 764
2019
Q4
$3.64M Sell
57,326
-9,900
-15% -$491K 0.03% 608
2019
Q3
$1.9M Sell
67,226
-5,400
-7% -$160K 0.01% 920
2019
Q2
$1.93M Buy
72,626
+39,626
+120% +$870K 0.01% 908
2019
Q1
$605K Hold
33,000
﹤0.01% 1143
2018
Q4
$409K Buy
+33,000
New +$451K ﹤0.01% 1201

Other funds holding ARWR

Mackay Shields LLC's ARWR Position: Q2 2021 in Review

Mackay Shields LLC sold out of Arrowhead Research (ARWR) in Q2 2021, closing a stake of 32,600 shares — an estimated $2.16M sold.

Mackay Shields LLC first reported a position in ARWR in Q4 2018 and held it in 10 quarters. The position peaked at $4.07M in Q4 2020. 314 funds tracked by Wall St. Rank hold ARWR as of Q2 2021.

  • Mackay Shields LLC reported no remaining Arrowhead Research position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 32,600 Arrowhead Research shares in Q2 2021, an estimated $2.16M.
  • Mackay Shields LLC first reported a position in Arrowhead Research in Q4 2018 and held it in 10 quarters.
  • Mackay Shields LLC's Arrowhead Research position peaked at $4.07M in Q4 2020.
  • 314 funds tracked by Wall St. Rank held Arrowhead Research as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.